Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. (Q47655009)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Lucie Peduto

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

13

Matthew L Albert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

10

Caroline Demangel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Claire Biot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Cyrill A Rentsch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Joel R Gsponer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Frédéric D Birkhäuser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Hélène Jusforgues-Saklani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Fabrice Lemaître

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Charlotte Auriau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Alexander Bachmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

George N Thalmann

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

Science Translational Medicine

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

137ra72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

The BCG World Atlas: a database of global BCG vaccination policies and practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Macrophages and control of granulomatous inflammation in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Cell-mediated immune responses in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Initiation and regulation of T-cell responses in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Detection of bacillus Galmette-Guérin (Mycobacterium bovis BCG) DNA in urine and blood specimens after intravesical immunotherapy for bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Mouse orthotopic models for bladder cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Analysis of mucosal bladder leucocyte subpopulations in patients treated with intravesical Bacillus Calmette-Guerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

A delicate dance: host response to mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Bacille-Calmette Guèrin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Additional bacillus Calmette-Guérin therapy for recurrent transitional cell carcinoma after an initial complete response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

Inflammation recapitulates the ontogeny of lymphoid stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003586

10.1126/SCITRANSLMED.3003586

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674550%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference